Cargando…
Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI
OBJECTIVES: To assess DWI for tumor visibility and breast cancer detection by the addition of different synthetic b-values. METHODS: Eighty-four consecutive women who underwent a breast-multiparametric-MRI (mpMRI) with enhancing lesions on DCE-MRI (BI-RADS 2–5) were included in this IRB-approved ret...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755636/ https://www.ncbi.nlm.nih.gov/pubmed/32780207 http://dx.doi.org/10.1007/s00330-020-07094-z |
_version_ | 1783626390756655104 |
---|---|
author | Daimiel Naranjo, Isaac Lo Gullo, Roberto Saccarelli, Carolina Thakur, Sunitha B. Bitencourt, Almir Morris, Elizabeth A. Jochelson, Maxine S. Sevilimedu, Varadan Martinez, Danny F. Pinker-Domenig, Katja |
author_facet | Daimiel Naranjo, Isaac Lo Gullo, Roberto Saccarelli, Carolina Thakur, Sunitha B. Bitencourt, Almir Morris, Elizabeth A. Jochelson, Maxine S. Sevilimedu, Varadan Martinez, Danny F. Pinker-Domenig, Katja |
author_sort | Daimiel Naranjo, Isaac |
collection | PubMed |
description | OBJECTIVES: To assess DWI for tumor visibility and breast cancer detection by the addition of different synthetic b-values. METHODS: Eighty-four consecutive women who underwent a breast-multiparametric-MRI (mpMRI) with enhancing lesions on DCE-MRI (BI-RADS 2–5) were included in this IRB-approved retrospective study from September 2018 to March 2019. Three readers evaluated DW acquired b-800 and synthetic b-1000, b-1200, b-1500, and b-1800 s/mm(2) images for lesion visibility and preferred b-value based on lesion conspicuity. Image quality (1–3 scores) and breast composition (BI-RADS) were also recorded. Diagnostic parameters for DWI were determined using a 1–5 malignancy score based on qualitative imaging parameters (acquired + preferred synthetic b-values) and ADC values. BI-RADS classification was used for DCE-MRI and quantitative ADC values + BI-RADS were used for mpMRI. RESULTS: Sixty-four malignant (average = 23 mm) and 39 benign (average = 8 mm) lesions were found in 80 women. Although b-800 achieved the best image quality score, synthetic b-values 1200–1500 s/mm(2) were preferred for lesion conspicuity, especially in dense breast. b-800 and synthetic b-1000/b-1200 s/mm(2) values allowed the visualization of 84–90% of cancers visible with DCE-MRI performing better than b-1500/b-1800 s/mm(2). DWI was more specific (86.3% vs 65.7%, p < 0.001) but less sensitive (62.8% vs 90%, p < 0.001) and accurate (71% vs 80.7%, p = 0.003) than DCE-MRI for breast cancer detection, where mpMRI was the most accurate modality accounting for less false positive cases. CONCLUSION: The addition of synthetic b-values enhances tumor conspicuity and could potentially improve tumor visualization particularly in dense breast. However, its supportive role for DWI breast cancer detection is still not definite. KEY POINTS: • The addition of synthetic b-values (1200–1500 s/mm(2)) to acquired DWI afforded a better lesion conspicuity without increasing acquisition time and was particularly useful in dense breasts. • Despite the use of synthetic b-values, DWI was less sensitive and accurate than DCE-MRI for breast cancer detection. • A multiparametric MRI modality still remains the best approach having the highest accuracy for breast cancer detection and thus reducing the number of unnecessary biopsies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-020-07094-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7755636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-77556362020-12-28 Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI Daimiel Naranjo, Isaac Lo Gullo, Roberto Saccarelli, Carolina Thakur, Sunitha B. Bitencourt, Almir Morris, Elizabeth A. Jochelson, Maxine S. Sevilimedu, Varadan Martinez, Danny F. Pinker-Domenig, Katja Eur Radiol Breast OBJECTIVES: To assess DWI for tumor visibility and breast cancer detection by the addition of different synthetic b-values. METHODS: Eighty-four consecutive women who underwent a breast-multiparametric-MRI (mpMRI) with enhancing lesions on DCE-MRI (BI-RADS 2–5) were included in this IRB-approved retrospective study from September 2018 to March 2019. Three readers evaluated DW acquired b-800 and synthetic b-1000, b-1200, b-1500, and b-1800 s/mm(2) images for lesion visibility and preferred b-value based on lesion conspicuity. Image quality (1–3 scores) and breast composition (BI-RADS) were also recorded. Diagnostic parameters for DWI were determined using a 1–5 malignancy score based on qualitative imaging parameters (acquired + preferred synthetic b-values) and ADC values. BI-RADS classification was used for DCE-MRI and quantitative ADC values + BI-RADS were used for mpMRI. RESULTS: Sixty-four malignant (average = 23 mm) and 39 benign (average = 8 mm) lesions were found in 80 women. Although b-800 achieved the best image quality score, synthetic b-values 1200–1500 s/mm(2) were preferred for lesion conspicuity, especially in dense breast. b-800 and synthetic b-1000/b-1200 s/mm(2) values allowed the visualization of 84–90% of cancers visible with DCE-MRI performing better than b-1500/b-1800 s/mm(2). DWI was more specific (86.3% vs 65.7%, p < 0.001) but less sensitive (62.8% vs 90%, p < 0.001) and accurate (71% vs 80.7%, p = 0.003) than DCE-MRI for breast cancer detection, where mpMRI was the most accurate modality accounting for less false positive cases. CONCLUSION: The addition of synthetic b-values enhances tumor conspicuity and could potentially improve tumor visualization particularly in dense breast. However, its supportive role for DWI breast cancer detection is still not definite. KEY POINTS: • The addition of synthetic b-values (1200–1500 s/mm(2)) to acquired DWI afforded a better lesion conspicuity without increasing acquisition time and was particularly useful in dense breasts. • Despite the use of synthetic b-values, DWI was less sensitive and accurate than DCE-MRI for breast cancer detection. • A multiparametric MRI modality still remains the best approach having the highest accuracy for breast cancer detection and thus reducing the number of unnecessary biopsies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-020-07094-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-08-11 2021 /pmc/articles/PMC7755636/ /pubmed/32780207 http://dx.doi.org/10.1007/s00330-020-07094-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Breast Daimiel Naranjo, Isaac Lo Gullo, Roberto Saccarelli, Carolina Thakur, Sunitha B. Bitencourt, Almir Morris, Elizabeth A. Jochelson, Maxine S. Sevilimedu, Varadan Martinez, Danny F. Pinker-Domenig, Katja Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title | Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title_full | Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title_fullStr | Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title_full_unstemmed | Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title_short | Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI |
title_sort | diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric mri |
topic | Breast |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755636/ https://www.ncbi.nlm.nih.gov/pubmed/32780207 http://dx.doi.org/10.1007/s00330-020-07094-z |
work_keys_str_mv | AT daimielnaranjoisaac diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT logulloroberto diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT saccarellicarolina diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT thakursunithab diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT bitencourtalmir diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT morriselizabetha diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT jochelsonmaxines diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT sevilimeduvaradan diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT martinezdannyf diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri AT pinkerdomenigkatja diagnosticvalueofdiffusionweightedimagingwithsyntheticbvaluesinbreasttumorscomparisonwithdynamiccontrastenhancedandmultiparametricmri |